Back
Astrana Health Vs. Blueprint Medicines Industry Stock Comparison
Sell
24
ASTH
Astrana Health
Last Price:
$31.1500
Seasonality Move:
4.29%
Sell
43
BPMC
Blueprint Medicines
Last Price:
$102.47
Seasonality Move:
5.27%
Sell
24
Astrana Health (ASTH)
is a Sell
Is Astrana Health a Buy, Sell or Hold?
-
The current Astrana Health [ASTH] share price is $30.2800. The Score for ASTH is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
-
ASTH is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Blueprint Medicines (BPMC)
is a Sell
Is Blueprint Medicines a Buy, Sell or Hold?
-
The current Blueprint Medicines [BPMC] share price is $103.36. The Score for BPMC is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
BPMC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ASTH Stock Price Chart
What is Astrana Health's stock price today?
-
The Astrana Health share price today is $30.2800Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ASTH is experiencing slight buying pressure.
BPMC Stock Price Chart
What is Blueprint Medicines's stock price today?
-
The Blueprint Medicines share price today is $103.36Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPMC is experiencing buying pressure, which is a positive indicator for future bullish movement.
ASTH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3 | Sell |
Relative Strength Index (14 RSI): | 25.38 | Sell |
Chaikin Money Flow: | 133096 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (31.1702 - 38.3302) | Sell |
Bollinger Bands (100): | (38.0648 - 56.9848) | Sell |
BPMC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.02 | Buy |
Relative Strength Index (14 RSI): | 65.19 | Buy |
Chaikin Money Flow: | 1951173 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (88.25 - 95.81) | Buy |
Bollinger Bands (100): | (87.04 - 95.76) | Buy |
ASTH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 31.22 | Sell |
20-day SMA: | 33.32 | Sell |
50-day SMA: | 40.64 | Sell |
200-day SMA: | 44.92 | Sell |
8-day EMA: | 31.23 | Sell |
20-day EMA: | 33.67 | Sell |
50-day EMA: | 39.33 | Sell |
200-day EMA: | 43.74 | Sell |
BPMC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 91.01 | Buy |
20-day SMA: | 91.26 | Buy |
50-day SMA: | 93.56 | Buy |
200-day SMA: | 96.81 | Buy |
8-day EMA: | 92.7 | Buy |
20-day EMA: | 91.91 | Buy |
50-day EMA: | 92.32 | Buy |
200-day EMA: | 91.6 | Buy |
Astrana Health Earnings Growth & ASTH Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.27 per share, and an increase next year of $0.50 per share.
Blueprint Medicines Earnings Growth & BPMC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.71 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and an increase next year of $2.89 per share.
Astrana Health Technical Analysis
Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Blueprint Medicines Technical Analysis
Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |